A compound for use in treating kidney diseases, wherein said compound is an ABCA1 inducer compound characterized in that it is represented by the formula I wherein one of A 1 and A 2 is N and the other one of A 1 and A 2 is CH; R 1 is selected from the group consisting of C 1-7 -alkyl, C 3-7 -cycloalkyl, C 3-7 -cycloalkyl-C 1-7 -alkyl, C 1-7 -alkoxy-C 1-7 -alkyl, halogen-C 1-7 -alkyl, heterocyclyl-C 1-7 -alkyl wherein the heterocyclyl group is unsubstituted or substituted by oxo, and heteroaryl-C 1-7 -alkyl wherein the heteroaryl group is unsubstituted or mono- or disubstituted by lower alkyl; R 2 and R 6 independently from each other are hydrogen or halogen; R 3 and R 5 independently from each other are selected from the group consisting of hydrogen, C 1-7 -alkyl, C 1-7 -alkoxy, halogen, halogen-C 1-7 -alkyl, halogen-C 1-7 -alkoxy and cyano; R 4 is selected from the group consisting of hydrogen, C 1-7 -alkyl, C 1-7 -alkoxy, halogen, halogen-C 1-7 -alkyl, halogen-C 1-7 -alkoxy, amino and cyano; R 7 is selected from the group consisting of C 1-7 -alkyl, C 3-7 -cycloalkyl, said cycloalkyl being unsubstituted or substituted by hydroxy, heterocyclyl, said heterocyclyl having 3 to 7 ring atoms, comprising one, two or three heteroatoms selected from N, O and S and being unsubstituted or substituted by hydroxy or oxo, phenyl, wherein phenyl is unsubstituted or substituted by one or two groups selected from the group consisting of C 1-7 -alkyl, hydroxy, C 1-7 -alkoxy, cyano, halogen and halogen-C 1-7 -alkyl, and heteroaryl, wherein heteroaryl is unsubstituted or substituted by one or two groups selected from the group consisting of C 1-7 -alkyl, hydroxy, C 1-7 -alkoxy, cyano, halogen and halogen-C 1-7 -alkyl, and G is selected from the group consisting of -(CH 2)m-, wherein m is selected from 0 or 1, and -NR 8 -, wherein R 8 is hydrogen or C 1-7 -alkyl, and pharmaceutically acceptable salts thereof. one of A 1 and A 2 is N and the other one of A 1 and A 2 is CH; R 1 is selected from the group consisting of C 1-7 -alkyl, C 3-7 -cycloalkyl, C 3-7 -cycloalkyl-C 1-7 -alkyl, C 1-7 -alkoxy-C 1-7 -alkyl, halogen-C 1-7 -alkyl, heterocyclyl-C 1-7 -alkyl wherein the heterocyclyl group is unsubstituted or substituted by oxo, and heteroaryl-C 1-7 -alkyl wherein the heteroaryl group is unsubstituted or mono- or disubstituted by lower alkyl; heterocyclyl-C 1-7 -alkyl wherein the heterocyclyl group is unsubstituted or substituted by oxo, and heteroaryl-C 1-7 -alkyl wherein the heteroaryl group is unsubstituted or mono- or disubstituted by lower alkyl; R 2 and R 6 independently from each other are hydrogen or halogen; R 3 and R 5 independently from each other are selected from the group consisting of hydrogen, C 1-7 -alkyl, C 1-7 -alkoxy, halogen, halogen-C 1-7 -alkyl, halogen-C 1-7 -alkoxy and cyano; R 4 is selected from the group consisting of hydrogen, C 1-7 -alkyl, C 1-7 -alkoxy, halogen, halogen-C 1-7 -alkyl, halogen-C 1-7 -alkoxy, amino and cyano; R 7 is selected from the group consisting of C 1-7 -alkyl, C 3-7 -cycloalkyl, said cycloalkyl being unsubstituted or substituted by hydroxy, heterocyclyl, said heterocyclyl having 3 to 7 ring atoms, comprising one, two or three heteroatoms selected from N, O and S and being unsubstituted or substituted by hydroxy or oxo, phenyl, wherein phenyl is unsubstituted or substituted by one or two groups selected from the group consisting of C 1-7 -alkyl, hydroxy, C 1-7 -alkoxy, cyano, halogen and halogen-C 1-7 -alkyl, and heteroaryl, wherein heteroaryl is unsubstituted or substituted by one or two groups selected from the group consisting of C 1-7 -alkyl, hydroxy, C 1-7 -alkoxy, cyano, halogen and halogen-C 1-7 -alkyl, and C 3-7 -cycloalkyl, said cycloalkyl being unsubstituted or substituted by hydroxy, heterocyclyl, said heterocyclyl having 3 to 7 ring atoms, comprising one, two or three heteroatoms selected from N, O and S and being unsubstituted or substituted by hydroxy or oxo, phenyl, wherein phenyl is unsubstituted or substituted by one or two groups selected from the group consisting of C 1-7 -alkyl, hydroxy, C 1-7 -alkoxy, cyano, halogen and halogen-C 1-7 -alkyl, and heteroaryl, wherein heteroaryl is unsubstituted or substituted by one or two groups selected from the group consisting of C 1-7 -alkyl, hydroxy, C 1-7 -alkoxy, cyano, halogen and halogen-C 1-7 -alkyl, and G is selected from the group consisting of -(CH 2)m-, wherein m is selected from 0 or 1, and -NR 8 -, wherein R 8 is hydrogen or C 1-7 -alkyl, -(CH 2)m-, wherein m is selected from 0 or 1, and -NR 8 -, wherein R 8 is hydrogen or C 1-7 -alkyl, and pharmaceutically acceptable salts thereof.